The hsp90 inhibitor onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach

HIGHLIGHTS

• who: The HSP et al. from the DepartmentUppsala University have published the Article: The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach, in the Journal: Scientific Reports Scientific Reports of 29/01/2020
• what: The authors investigate combination treatment of HSP90 inhibitor Onalespib with external beam radiotherapy in_vitro and in_vivo, to further elucidate the potential mechanisms behind the proposed effects, and to assess treatment efficacy and potential toxicity of such a combination in_vivo, using two human xenograft mouse models with different radiosensitivities. The authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.